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ABSTRACT  
Investigating crystal nucleation at the nanoscale is of significant interest, in particular as more 
complex, non-classical routes have roused questions about the classical view of homo- and 
hetero-nucleation processes. Here, we report the direct observation of a two-step nucleation 
mechanism during the transformation of anhydrous olanzapine to olanzapine dihydrate. Atomic 
force microscopy studies of the dominant (100)OZPNI face of olanzapine form I single crystals in 
contact with water show the formation and growth of dense nanodroplets concentrated at the 
steps. In unstirred solution, apparent ordering and crystallization from these droplets occurs with 
olanzapine dihydrate D produced by the templating effect of the underlying olanzapine I lattice. 
In contrast, under stirred conditions a kinetic dihydrate polymorph, dihydrate B, nucleates 
probably due to the detachment of nanodroplets from the surface during stirring and a 
consequent loss of template effect. Computational modelling of the binding of olanzapine growth 
units on crystal step reveals many strongly bound dimer positions unrelated to either crystal 
structure. This impedes surface integration and contributes to the growth of disordered clusters at 
the ledge site. Nanocrystal modelling shows that the (100)OZPNI surface favours the nucleation of  
dihydrate D over the kinetic form. This work gives an important insight into heterogeneous two 
step nucleation where the first step, the formation of a prenucleation droplet, can in the second 
step, bifurcate, either to produce the stable form by templating, or the kinetic form on 
detachment of the nanodroplets. 
INTRODUCTION  
Crystallization is widely used to control the purity and solid-state properties of active 
pharmaceutical ingredients (API) and others chemicals. Despite its widespread application in 
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industrial processes crystal nucleation and growth remain poorly understood. Hence, the study of 
early stages of crystal formation provides the opportunity to develop improved methods to 
control crystallization outcomes including size,1 purity,2 morphology,3 crystal structure,4 and the 
stability and performance of APIs. Nucleation and growth processes are difficult to monitor 
experimentally at the molecular level due to the short length and timescales typically involved, 
however considerable efforts continue to be devoted to understanding nucleation processes5 
including using dynamic simulations.6 Classical Nucleation Theory (CNT 7Ð11) is widely applied 
to describe crystal nucleation kinetics from solution, however it cannot faithfully explain all 
observed phenomena. Recent studies have shown evidence of a two-step nucleation process12Ð15 
in which the initial formation of clusters of a dense, disordered, liquid-like phase precedes the 
formation of an ordered solid nucleus inside the clusters. Evidence for two-step nucleation has 
been observed in protein crystallisation16Ð19 with the existence of pre-nucleation clusters (PNCs) 
comprising small, thermodynamically stable solute clusters also being reported for inorganic 
systems including calcium carbonate and calcium phosphate.20Ð23 It has been proposed20 that 
within PNCs local ordering of structural motifs corresponding to specific crystalline polymorphs 
can occur, influencing the resultant crystal form obtained. The formation of dense clusters has 
also been observed in aqueous solutions of organic molecules (including several amino acids 
such as glycine, aniline and DL-valine24Ð27), polymers28 and inorganic structures including 
heteropolyacids29 and InP quantum dots.30 The increasing evidence for two-step nucleation in 
organic, protein and inorganic systems suggests it may play a significant role in the formation of 
crystals under many different situations.  
A two-step nucleation mechanism was proposed during the heterogeneous nucleation of 
organic molecules on carbon nanohorns.31 The impurity surface may have the ability to induce 
 4 
order within the dense pre-nucleation clusters and lower the surface free energy for nucleation as 
well as effectively template the resultant crystal form. There is therefore also considerable 
interest in the mechanisms controlling heterogeneous nucleation templating with surface 
topology,32,33 lattice matching,34Ð37 and molecular functionality38Ð40 factors influencing the process. 
Clearly, a better understanding of how surfaces can influence the structure of PNCs could 
provide a basis to select or design surfaces that specifically template crystalline materials with 
desirable solid-state properties.34,37 The key solid state properties of APIs include size, shape, 
crystal structure, surface properties, solubility, dissolution rate and stability. Hydrate formation is 
of particular importance due to the widespread exposure of APIs to water, whether in solution or 
vapor form, since the incorporation of water molecules in the crystal lattice can have a dramatic 
effect on solubility and possibly bioavailability of an API. The ongoing development of theories 
for nucleation and the role of surfaces on heteronucleation processes clearly needs further 
investigation, exploiting techniques that can operate at the nanoscale. One such technique is 
atomic force microscopy (AFM), commonly regarded as a surface-specific technique, with 
promising applications in various aspects of API characterization, such as crystal growth,41,42 
surface morphology,43 phase changes44 and dissolution.45  
Olanzapine (OZPN, Zyprexa¨, Figure 1a)46 is a BCS class II drug used in schizophrenia 
treatment. To date, 60 distinct OZPN forms have been identified, including three polymorphic 
forms (I, II, III), where form I is the most stable non-solvated form.47 The drug also forms three 
polymorphic dihydrates (B, D, E) and a disordered higher hydrate, with the hydrate formation 
pathway depending on the starting form and water activity.48 Structural analysis showed that 
OZPN I shares 1−D structural similarity with olanzapine dihydrate B (OZPN DB), dihydrate E 
and the higher hydrate and 2−D structural similarity to dihydrate D (OZPN DD).49 Whilst all neat 
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and solvated solid forms of OZPN contain a centrosymmetric (OZPN)2 dimer (SC0) as a common 
structural building block (Figure 1c), the divalent cation has a non-dimeric packing arrangement 
in a number of OZPN salts.50,51 Crystal structure prediction (CSP) calculations have also 
indicated that OZPN structures without the dimeric motif are also thermodynamically feasible 
however have yet to be observed experimentally.47 OZPN and OZPN hydrates exhibit low 
aqueous solubility and there is interest in studying the mechanism of anhydrate to hydrate 
formation given the potential impact on performance and stability of OZPN shown in the study 
of Paisana et. al.48 In 93% relative humidity (RH), the moisture level drove the transformation of 
OZPN I to OZPN DD, while form II (containing form III as a phase impurity) was converted to 
OZPN DB. In a stirred aqueous environment, both forms were first transformed to kinetic OZPN 
DB (within 24 hours) and then to the more stable OZPN DD (after five days) suggesting either a 
solid-solid transformation or solution mediated transformation when exposed to controlled 
humidity or placed in direct contact with water respectively. Additionally, the structural 
similarities between the OZPN forms and corresponding dihydrates direct the different hydration 
outcomes under 93% RH.   
In the case of OZPN, the impact of dissolution properties on drug product performance is 
critical. Conversion to a more stable, less soluble hydrated form could compromise dissolution, 
however, transformations limited to the surface of the crystal would be difficult to detect by 
conventional techniques, e.g. XRPD. For this reason, crystals are typically suspended in aqueous 
solutions and stirring is used to drive transformations more or less to completion by continually 
refreshing the surface.  It is generally assumed that transformations at extremely high humidity 
are the same but slower than those in stirred aqueous suspensions. Hence the present study 
investigates the heterogeneous nucleation of OZPN hydrates on anhydrous OZPN I crystals in 
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aqueous suspension and on exposure to humidity, using AFM. Following on previous work48 this 
report investigates the effects of water activity, local mixing and structure on OZPN hydrate 
formation on the dominant face of OZPN I and provides evidence for two-step nucleation and 
surface templating. Extensive computational modelling including lattice matching, nanocrystal 
attachment and localized ledge interactions are used to explain the formation of the disordered 
phase and templating effect of the (100)OZPNI face for OZPN DD. 
 
MATERIALS AND METHODS 
Materials. All analytical grade solvents were purchased from Fisher Scientific, UK. NaCl 
(anhydrous, ≥99.5%) was purchased from Sigma Aldrich UK, and OZPN from Molekula Ltd., 
UK, confirmed as form I by X-ray powder diffraction (XRPD), was used without further 
purification. 
 Crystallization. OZPN I and OZPN dihydrates were prepared according to the methods 
described by Reutzel-Edens et. al.49 Single crystals of OZPN I were obtained by dissolving ~200 
mg of OZPN in 30 ml of ethyl acetate. The solution was stirred and heated to ensure complete 
dissolution of OZPN. The solution was then filtered through a 0.45 μm PTFE filter, transferred 
to 5 ml glass vials, sealed and kept at room temperature (RT) for 3−5 days without stirring. The 
resulting crystals were filtered under vacuum and washed with a 1:1 ethyl acetate/ hexane 
mixture to remove any surface deposited material. Crystals were dried on a filter paper in a 
desiccator over a silica drying agent. OZPN DB and OZPN DD for Raman measurements were 
obtained by stirring ~200 mg of OZPN I in 3 ml of water for 6 h and 8 days respectively. The 
presence of each dihydrate polymorph was then confirmed by XRPD.  
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OZPN I single crystal in water experiments. OZPN I single crystals (size between 1−1.5 
mm) were attached to the end of a glass capillary with epoxy glue, oriented so that {100}OZPNI 
planes were exposed perpendicular to the capillary axis. The capillary was suspended in water so 
that when stirring was applied, the magnetic stirrer placed at the bottom of the vial was not in 
close contact with the crystal at the tip. Where specified as Ôstirring conditionsÕ, the stirring rate 
was set as 100 rpm, otherwise no stirring was used. All experiments were performed at RT. 
Raman Spectroscopy. Raman spectra were collected using a Thermo Scientificª DXR 
Raman microscope with a 532 nm (diode-pumped, solid state) laser excitation source and CCD 
equipped with a high precision X, Y, Z motorized stage in the shift region of 50−3400 cm−1 over 
10 scans using a resolution of 1 cm−1. 
Optical Microscopy. Optical images were obtained using a Leica DM6000M optical 
microscope equipped with a motorized stage and Leica DFC495 camera. Images were analyzed 
using LAS v.4.8 software (Leica). 
 X-ray Powder Diffraction (XRPD). XRPD patterns were obtained using a Bruker AXS D8-
Advance transmission diffractometer equipped with θ/θ geometry, primary monochromated 
radiation (Cu, λ = 1.54056 ). Data were collected in the 2θ range of 4−35¡ with a 0.015¡ 2θ 
step and 1 s/step speed.  Reference powder patterns were produced using the Mercury 3.6 
(CCDC) software from single crystal data (CSD ref. code OZPN I: UNOGIN01, OZPN DD: 
AQOMAU, OZPN DB: AQOMAU03). 
Single Crystal Face Indexing. Crystals were indexed using a Bruker D8 Venture 
diffractometer equipped with a CCD detector and using graphite-monochromated Cu Kα 
radiation (λ=1.54056 ) and an APEX-3 face indexing plug-in. 
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Atomic Force Microscopy (AFM). AFM data were collected using a Dimension Icon AFM 
(Bruker) using PeakForce Tapping¨ mode at RT and a ScanAsyst Air probe (Bruker) with 
nominal spring constant k =0.4 N/m and a nominal tip radius of 2 nm.  
AFM experiment in controlled relative humidity. OZPN I crystals were analyzed at ambient 
(35 %) and higher (75 %) RH, with the latter achieved from ambient humidity using a saturated 
solution of NaCl and monitored throughout using a humidity sensor (Fisher Scientific). OZPN I 
crystals were mounted using double sided tape. Crystals were stored in a desiccator before 
analysis with no additional modification of crystal surfaces carried out before the measurements.  
AFM experiments in water. OZPN I crystals were mounted with epoxy glue to a cover slip 
and placed in a crystallization dish, which was submerged in 5 ml of deionized water with no 
applied solution flow. Images were acquired using a ScanAsyst Fluid probe (Bruker) with 
nominal spring constant k =0.7 N/m and a nominal tip radius of 2 nm. 
AFM Image Processing. All AFM data was analyzed using NanoScope Analysis 1.5 software 
(Bruker). Height images were corrected by first order flattening.  
Simulations. Morphology predictions. Crystal structures were geometrically optimized using 
the COMPASS force field in the Forcite module in Materials Studio 7.0 (Accelrys Software 
Inc.). The Quasi-Newton algorithm was used with convergence tolerance for energy of 2.0 x 10-5 
kcal/mol, a force of 0.001 kcal/mol/, and the displacement of 1.0 x 10-5 . Growth morphology 
models of OZPN I, OZPN DD, OZPN DB were calculated using the Morphology Module 
(COMPASS force field with the Ewald summation method for electrostatic and van der Waals 
interactions with accuracy of 1.0 x 10-5 kcal/mol with a buffer width 0.5 ). The BFDH 
morphology models were generated using the Morphology Module with minimum interplanar 
distance dhkl = 0.8 . 
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Epitaxial Matching Calculations. Epitaxial matching calculations were implemented using 
the GRACE (Geometric Real-space Analysis of Crystal Epitaxy)52 software package version 4.1. 
Epitaxial scores (E) between (100)OZPNI and (001)OZPNDD or (100)OZPNDB were calculated by the 
summation of near coinciding lattice points between (100)OZPNI substrate and an overlayer of 
dihydrate as a function of the azimuthal angle between the two lattices36 for various search areas 
(ESI section 2 for details). 
Modelling with atomistic models for the intermolecular forces. The intermolecular 
electrostatic interactions were modelled using distributed multipole models53 of the PBE0/6-
31G(d, p) charge density of isolated OZPN and water molecules, to include the dominant 
anisotropy of the hydrogen bonding and π−π electrostatic interactions. All other intermolecular 
interactions were modelled by an atom-atom exp-6 repulsion-dispersion potential using the 
empirically fitted FIT potential parameters.54 This type of model has been extensively used in 
crystal structure prediction studies55,56 including for olanzapine47 and organic hydrates.57,58 The 
rigid-molecule modelling for crystal structures used DMACRYS54. A variety of 
molecule!molecule, molecule!surface, molecule!ledge and nanocrystal!surface constructs 
were modelled using the same intermolecular potential within ORIENT,59 exploiting its 
capabilities for specific construction of an infinite perfect surface combined with other molecular 
units.60 Complete details are provided in the ESI. 
 
RESULTS  
Characterization of OZPN I crystals 
Form I OZPN is the most stable non-solvated crystal form and crystallizes in space group 
P21/c.
47,49 Single crystals can be obtained from several anhydrous solvents including ethyl 
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acetate, isopropyl acetate, butyl acetate, isobutyl acetate, diethyl ether, diisopropyl ether, toluene, 
and fluorotoluene.47 Crystals prepared by slow evaporation of ethyl acetate solution are light 
yellow in color and show a rhombohedral morphology with large {100}OZPNI faces and other 
smaller faces (Figure 1b; face-indexing of form I is shown in Figure S1a,b). Analysis of the 
crystal structure of OZPN I shows that hydrogen bonds link the centrosymmetric SC0 OZPN 
dimers47 into 2D layers parallel to (100)OZPNI (the orientation of the dimers on the (100)OZPNI face 
is shown in Figure 1c). With only the aromatic and methyl groups of OZPN decorating the 
(100)OZPNI surface, this face has a decidedly hydrophobic character. The dominant (100)OZPNI face 
observed from recrystallized samples is also the largest face present in the BFDH predicted 
morphology (Figure S2a), and is the face with the smallest attachment energy based on growth 
morphology calculation (Figure S2b, Table S1). 
Crystals (1 − 1.5 mm in size) grown from ethyl acetate solution were filtered, washed and dried 
(see Methods section). Optical microscopy shows well-formed facets (Figure 1b) and nanoscale 
surface characterization by AFM reveals a detailed ledge and terrace structure on the (100)OZPNI 
surfaces (Figure 2a).  The ledges steps show a high kink density from the conditions used in their 
growth and preparation (Figure 2a), with a considerable number of them being (020)OZPNI steps 
comprising an (100)OZPNI terrace and [001]OZPNI  ledges at an angle θOZPNI = 90¡ (Figure 1d). The 
measured step height (h100 = 10.12 ± 0.81 ) correlates closely to the distance measured between 
(100) planes in an OZPN I crystal (d100 = 10.17 ). 
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Figure 1 a) Molecular structure of OZPN. Numbering of the atoms according to reference47; b) 
single crystal of OZPN I obtained from slow evaporation of ethyl acetate solution, with face 
indices annotated (Figure S1); c) crystal structure of OZPN I (100)OZPNI face, showing SC0 dimer 
pairs and d) schematic of (100)OZPNI crystal surface features observed using AFM (see Figure 2d). 
Nanoscale surface transformation in a humidity-controlled environment  
In situ AFM was used to investigate the mechanism of growth of OZPN DD on the surface of 
(100)OZPNI. Imaging was carried out under both ambient (35% RH) and high humidity (75% RH) 
conditions for 150 min and 6 h respectively. Prior to the measurements, crystals were maintained 
over a silica desiccant to prevent initiation of hydrate formation and surfaces were analyzed 
without additional cleaning. Upon exposure of the crystal to 35 % RH, multiple dome-shaped 
nanodroplets formed preferentially at high-energy kinks, steps or defect sites on the (100)OZPNI  
terrace (Figure 2 a−f). The initial diameter of the nanodroplets after 7 minutes (Figure 2f) was 
39.64 ± 2.37 nm (n = 30 droplets). Under these conditions growth of nanodroplets appears to be 
associated with slow dissolution of surrounding OZPN layers characterized by pit site formation 
on the crystal face and recession of step edges (Figure 2d). It is assumed that the nanodroplets 
contain both OZPN and water molecules as a disordered dense phase. Over time, droplet 
coalescence is observed with those > 80 nm in diameter growing whereas smaller nanodroplets 
 12 
(< 60 nm in diameter) reduce in size and disappear over time (see Figure 2e). Within 150 min, 
droplets grew to an average diameter of 139.84 ± 31.42 nm (n= 30, Figure 2f). 
 
Figure 2 Growth of droplets on the surface of (100)OZPNI at 35 % RH, AFM micrographs of 
(100)OZPNI showing surface changes (scan size 2.5 μm, z scale bar 10 nm) at: a) 0 min, b) 30 min, 
c) 113 min, d) magnification of droplets after 113 min showing pit site formation and receding 
step edges during droplet growth, e) cross-sections of the droplets during various times, and f) 
growth of nanodroplets diameter over time. Each point is an average of n=30 droplets. 
When OZPNI was subjected to 75 % RH (Figure S5) similar processes were observed, with 
coalescence of smaller droplets to form larger nanodroplets (102.77 ± 39.90 nm, n=30). When 
the crystal was held at 75 % RH for 14 days and re-analyzed, the (100)OZPNI surface was entirely 
covered with droplets (125.50 ± 23.27 nm, n=25) (see Supporting Information Figure S4e). 
Notably, no evidence of transformation of the nanodroplets to a new hydrated crystalline layer 
was observed. A previous report48 showed OZPN I gained very little moisture below 53 % RH (< 
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0.1 % w/w), increasing only slightly after 180 days at 75 % RH (0.27 ± 0.07 % w/w), indicating 
that complete bulk transformation of OZPN I to dihydrate did not occur under these conditions 
even after prolonged exposure. Raman microspectroscopy of the OZPN I single crystal stored for 
14 days in 75 % RH was unable to detect changes in the surface of OZPN I, most likely due to 
the very low thickness of the nanodroplet layer. However, based on the consistent droplet 
morphology there is no evidence to suggest that a transformation of the nanodroplets to a 
hydrated crystalline phase has initiated at 75 % RH within 2 weeks. 
Effect of stirring on OZPN dihydrate formation at (100)OZPNI solution interface 
In a stirred aqueous suspension of crystals, OZPN I transforms first to the kinetic OZPN DB 
within hours, followed by transformation to the most stable OZPN DD within days.48,49 To better 
understand these processes immobilized single crystals of OZPN I were suspended in water in 
vials with either gentle stirring (100 rpm) or quiescent, unstirred conditions for 48 h (Figure 3a). 
These different mixing environments for a suspended single crystal resulted in notable 
differences in the outcomes, and can be contrasted with conventional slurrying. In contrast with 
the OZPN humidity experiments, under all conditions, the formation of small plate-like 
crystallites was observed on the (100)OZPNI surface in water. However the orientation of the 
crystallites relative to the substrate crystal showed a dependence on stirring. When stirring was 
applied the microcrystallites did not exhibit significant preferential orientation relative to the 
substrate and were observed to be only loosely attached to the OZPN crystal surface. In contrast, 
microcrystallites grown under quiescent conditions were strongly bound to the (100)OZPNI crystal 
face and showed a significant and uniform degree of preferential orientation. 
Raman microspectroscopy was used to determine the solid-state form of the observed 
crystallites formed under both conditions and the resultant spectra were compared to reference 
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spectra for OZPN DB, OZPN DD, and OZPN I (Figure S3). The loosely bound crystallites 
obtained under stirred conditions were identified as OZPN DB, whilst the well-aligned, bound 
crystals produced under unstirred conditions were the thermodynamically stable dihydrate 
polymorph, OZPN DD. This was confirmed by single crystal X-ray analysis of crystallites 
carefully removed from the OZPN I samples surface. Face indexing of the dihydrate crystals 
(Figure S1c,d) allowed the relative orientation of OZPN DD and OZPN DB on the surface of 
(100)OZPNI to be determined. Morphological analysis of the OZPN DD and OZPN DB crystals 
identified that crystals grew with (001)OZPNDD and (100)OZPNDB parallel to (100)OZPNI respectively. 
The OZPN DB microcrystallites are randomly oriented on the surface of OZPN I, and so loosely 
adhered that they could be readily removed for analysis. This appears to be the result of 
crystallites forming close to the OZPN I surface rather in direct contact and remaining in close 
proximity rather than being cleared from the surface by shear and deposited elsewhere in the 
reactor. In contrast, OZPN DD crystallites were surface bound and oriented with [100]OZPNDD axis 
at 91¡ ± 2¡ with respect to [010]OZPNI direction (see Supporting Information Figure S7). 
The highly consistent orientation of OZPN DD microcrystals on OZPN I suggests a significant 
influence of the underlying OZPN I crystal structure on OZPN DD nucleation and growth under 
quiescent conditions. The strong dependence of the orientation between the substrate crystal and 
grown crystals is generally presumed to be controlled by an epitaxial mechanism, however 
GRACE analysis35,36,61 shows that there is no long range epitaxial match between the lattices of 
either dihydrate and the OZPN (100) face (ESI section 2).  
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Figure 3 Effect of stirring on anhydrate to dihydrate transition. a) experimental set up: crystals 
attached to glass capillaries were placed in sealed vials and kept for 48h in two different stirring 
conditions: gentle stirring (left; 100 rpm) and unstirred conditions (right). b) Optical image of the 
stirred (100)OZPNI surface of an OZPN I crystal with visible OZPN DB microcrystals after 6h, c) 
image showing OZPN DD microcrystals on OZPN I  after 48 h in unstirred solution. Observed 
crystal morphologies of d) OZPN I with dimeric motif on (100)OZPNI and e) OZPN DB 
microcrystallites and molecular arrangement on (100)OZPNDB face, f) OZPN DD microcrystallites 
and molecular arrangement on (001)OZPNDD face. Face-indexing and relative orientation of 
microcrystals on OZPN I substrate are described in the ESI (Figures S1 and S7). 
AFM studies on (100)OZPNI in water.  
The OZPN I to dihydrate transformation in water is clearly influenced by the applied 
stirring/shearing conditions. To further investigate this, several OZPN I crystals were suspended 
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in water and the (100)OZPNI face visualized by in situ AFM. Direct observation of the 
transforming surface using the scanning AFM probe can influence the surface.62 Therefore, in 
addition to continuous in situ monitoring over 24 h, periodic monitoring of OZPN I samples 
stored under water was carried out to assess any influence of localized perturbations from the 
moving AFM probe. 
Using longer scan intervals (2 h, 24 h, 24.5 h, 25 h and 48 h) the formation of the first 
nanodroplets occurred preferentially at the surface ledge together with local dissolution of OZPN 
(100) layers (Figure 4a). The fact these nanodroplets can be visualized in the aqueous 
environment, suggests they are significantly denser than liquid water and are OZPN-rich. The 
initial nanodroplet-like structures (lateral average diameter after 2 hours: 34 ± 6 nm, n=30) are 
shown in (Figure 4a). There is also evidence of the dynamic nature of nanodroplets movement 
across the surface, with partial coalescence observed between neighboring nanodroplets (two and 
many nanodroplets coalescing marked with dashed circle and yellow arrow respectively on 
Figure 4a, Figure S6). After 24 h, three scans with 30 min intervals were performed revealing a 
striking sequence of dynamic changes on the (100) OZPN I face. Coalescence of the 
nanodroplets progressively led to the formation of larger rounded rhombus-shaped features 
(Figure 4c, with height 127 ± 34.20 nm and diameter 10.51 ± 0.60 μm). In the periodic 
monitoring experiments after 24 h, continued growth of the feature in all three dimensions was 
observed (587.25 ± 24.60 nm, 15.94 ± 0.16 μm). Whilst the nanodroplet retains significant 
curvature (cross section Figure 4c) some partial ordering is apparent (e.g. emergence of more 
linear droplet edges) that may be a result of close association of the nanodroplet to the 
underlying crystal lattice of (100)OZPNI. Strikingly, after 48 h well-developed crystals are 
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observed with the same morphology and orientation as described above for OZPN DD on the 
(100)OZPNI  (Figure 4d, Figure S7d).  
After 2h of continuous scanning, formation of the nanodroplets was also observed. The 
nanodroplets could be easily moved, dragged or even torn off by lateral shear forces of the probe 
and continued development of larger features was not observed, possibly due to disruption of the 
process by the AFM tip (Figure S5). Whilst nanodroplets are still observed to coalesce, the 
continuous movement of the probe apparently interferes with the association of the nanodroplets 
to the (100)OZPNI face. Notably no transformation to OZPN DD crystal was observed under 
continuous scanning. Thus the induction time for nucleation of crystals of OZPN DD from 
undisturbed nanodroplets, templated on the OZPN I surface, is significantly longer than the time 
to form the droplets. Disruption of the droplets during this period inhibits templated nucleation 
of OZPN by the underlying surface from the droplets. 
 
Figure 4 AFM micrographs with the corresponding cross section of height (area marked with 
dotted white line) of the surface of (100)OZPNI  in water showing the evolution of size and ordered 
features after a) 2 h- visible droplets on the surface, droplet coalescence marked with yellow 
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arrow and two droplets coalescing marked with dashed circle b) 24 h- coalescence of the 
droplets, c) 25 h- large coalesced droplet rearranging into rhombus shape, d) 48 h- fully 
developed OZPN DD crystal.  
 
DISCUSSION 
Two-step nucleation process 
When OZPN I is exposed to humidity (93 % RH and above) or to an aqueous environment it 
undergoes transformation to the more stable OZPN dihydrate.47Ð49 The relatively slow rate of 
transformation of OZPN I to OZPN DD, with only partial surface transformation occurring after 
48 h allows detailed study of the process using AFM. Building on previous report,48 the 
transformation of OZPN I in water is strongly dependent upon stirring, with quiescent conditions 
leading to direct growth of OZPN DD. Whilst the oriented growth of the resultant OZPN DD on 
(100)OZPNI is itself a striking finding, the details of the dynamic changes at the surface that 
precede the formation of these crystals is particularly unexpected. The formation, coalescence 
and growth of dense droplets preceding the nucleation of OZPN DD is not consistent with CNT 
and it is therefore proposed that OZPN DD nucleation on the surface of OZPN I is actually a 
two-step nucleation process (Figure 5). Formation of dense liquid domains in the range of 
several hundred nanometers leads to an unstable liquid phase that undergoes reorganization in a 
later stage into an ordered crystalline structure via a two-step nucleation process,12Ð14,25,26,63 with 
the fundamental assumption of an increase in density prior to and separated from the 
development of crystallinity.13 
AFM studies show that, when OZPN I single crystals are exposed to humidity (35% RH), 
numerous nanodroplets form at high-energy kinks, ledges or defects on (100)OZPNI terraces 
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(Figure 5 A). Condensation of water on the surface, presumably leads to localized dissolution of 
OZPN and nanodroplets increase in size by short-range molecular diffusion of OZPN molecules 
from adjacent crystal ledges, further water condensation and coalescence (Figure 5 B). However, 
the transformation from OZPN I to hydrated form under this condition (35 % RH) was not 
observed, consistent with reports that it can only occur to a significant extent at above 93 % 
RH.48  
When suspended in aqueous solution, the aqueous OZPN nanodroplets can be visualised by 
AFM as a separate, solute rich dense liquid phase. Under quiescent conditions, the nanodroplets 
coalesce and transform to a mesoscopic feature with a rhombus shape (Figure 4c, and 5C). The 
shape of this feature is intriguing, evidently developing from the coalescence of smaller droplets 
and whilst no well-developed crystal facets are observed, the edges of the feature are 
approximately straight. The lateral profile of the observed mesodroplet (Figure 4c bottom) 
suggests that the nucleation process starts at the interface between (100)OZPNI and the droplet and 
appears strongly influenced by the crystal alignment of that face. The apparent evolution of 
ordering in the droplet suggests that nucleation occurs at the base of the drop in contact with the 
(100)OZPNI face and crystal growth progresses until the OZPN supersaturation has been consumed 
to form OZPN DD. Preferred orientation of OZPN DD microcrystallites on OZPN substrate 
suggests that (100)OZPNI plays a significant role in this process, templating the nucleation of 
OZPN DD from aggregated droplets (Figure 5D). 
Based on the bifurcated formation of OZPN DB and DD microcrystals under stirred and 
unstirred conditions respectively (Figure 5), it can be concluded that the nanodroplets do not 
exhibit encoded structural information corresponding to either specific crystalline polymorph.20 
Recent molecular simulations by Anwar et. al.64 showed that in situations where a crystal surface 
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is present in a supersaturated solution, weakly bound spherical clusters of solute molecules 
immediately nucleate, when these clusters are in close contact with the surface. Nucleated 
clusters could be easily removed from the surface by agitation, leaving the surface able to seed 
further secondary nucleation. Taking into consideration the soft properties of nanodroplets 
observed in aqueous OZPN, and the relative ease by which they can be relocated (such as by a 
moving AFM probe), it is proposed that when exposed to shear through stirring, droplets are 
removed from the templating (100)OZPNI surface (Figure 5E). These solute rich droplets then 
coalesce and nucleate the kinetically-favored form OZPN DB in free solution (Figure 5F and G), 
with no direct influence of (100)OZPNI. Further work to confirm the presence of OZPN rich 
droplets in water solution, for example using light scattering techniques, is beyond the scope of 
this study. Nevertheless, similar behavior has been reported for the dependence of the magnitude 
of the contact force used during microattrition on the polymorphic outcome of glycine: αÐ
glycine was found more likely to nucleate at low forces due to removal of glycine rich clusters 
from the γ-glycine crystals, while using high forces led to secondary nucleation of the γ form.65 
Complete transformation of the OZPN I substrate crystal to OZPN DD was not observed, during 
these experiments due to slow transformation kinetics combined with reduced driving force from 
partial surface coverage. 
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Figure 5 Schematic of the proposed nucleation process of OZPN DD on the surface of OZPN I 
crystal and OZPN DB in solution. Large steps (labeled A−D) represent major stages. In unstirred 
conditions nucleation follows A D path resulting in formation of templated OZPN DD where 
A) shows formation of the droplets at steps, B) coalescence of the droplets, C) formation of 
mesoscale droplets with emergence of crystalline features and D) fully developed OZPN DD 
crystal aligned on (100)OZPNI. Under stirred conditions, nucleation follows path E G where E) 
static layer around the crystal is disturbed and droplets transfer into bulk solution, F) droplets 
coalesce in solution and G) the kinetic form (OZPN DB) crystals nucleate and grow in free 
solution. 
Role of OZPN I as a template  
Heterogeneous nucleation is practically widespread, albeit with containers, stirrers, impurities, 
particles/dust acting as the surface enhancing nucleation rates and possibly influencing resultant 
crystalline properties of materials. It is known that nucleation of a crystal is favorable on 
surfaces, as the interface promotes nucleation by lowering the nucleation free energy barrier.66 
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Indeed, well-chosen crystal surfaces can work as templates to crystallize novel polymorphs of 
organic molecules.37 To date, three major factors have been described as responsible for 
successful polymorph selection on crystalline templates: lattice matching (2−D epitaxy),34Ð37 
molecular functionality of the substrate,38,67 and the substrate topology (ledge-directed epitaxy or 
LDE).32,33  However lattice matching and surface topology did not show sufficiently strong 
agreement between the substrate and the emergent form to suggest these were significant 
mechanisms for OZPN (ESI section 2).   
Modelling support for the two-step nucleation process 
 Why molecules may not bind easily in crystallographic growth sites at ledges. 
To rationalize our explanation of a two-step nucleation mechanism for OZPN DD on (100)OZPNI 
face, a series of atomistic simulations was carried out using ORIENT,59 exploiting its unique 
capabilities for modelling specific constructions on an infinite perfect surface.60 Since all 
experimentally observed neat and solvated OZPN structures contain SC0 dimers (Figure 1) which 
are strongly bound by dispersion interactions,47 the SC0 dimer was assumed as the basic growth 
unit. As (020)OZPNI steps comprising of (100)OZPNI terrace and [001]OZPNI ledge were observed in 
AFM experiments to have dense droplets forming on it under humid conditions (Figure 2d), a 
model of (020)OZPNI step with [001]OZPNI ledge was constructed (defined in ESI 3.2). A rigid SC0 
dimer was docked onto the rigid ledge model by energy optimization, starting from a grid of over 
70 different initial positions above the surface with the dimer in the crystallographic orientation. 
During the optimization, the dimer moves and rotates under the influence of intermolecular 
forces and torques and binds to different sites on the ledge. The simulations of docking sites on 
the (100)OZPNI surface and [001]OZPNI ledge showed that there exists a multitude of sites at various 
positions on the ledge onto which a dimer could potentially dock in different orientations (Figure 
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6). A significant proportion of the optimizations showed the OZPN SC0 dimer binding preferably 
to the ledge site, compared to a direct docking onto the (100)OZPNI face. Whilst the 
crystallographic positioning of the dimer at the kink site (Figure 7a) is by far the most stable 
position, it can only be achieved when the dimer is approaching the ledge with the correct 
orientation and direction of approach, and was only found three times, despite the starting point 
having the correct orientation. This is due to the SC0 dimer being a highly anisotropic growth 
unit which needs to attach to the ledge by directional hydrogen-bonds, in this case, the N1-N2 
sites on two adjacent SC0 dimers on the ledge, and the difficulty orienting itself correctly before 
docking onto the ledge. Thus the dimer was far more likely to become trapped in one of the other 
non-crystallographic positions, a few of which are shown in Figure 7 b−e. Many of these 
positions are significantly more stable than a dimer docking onto the perfect surface which is 
very close to the crystallographic position, with a binding energy that is only slightly more stable 
than twice the attachment energy of -37.6 kJ/mol. Hence, it appears that the ledges are more 
likely to attract OZPN SC0 dimers from a range of orientations than the terraced surfaces, and 
consequently the dimeric growth units are expected to accumulate on the ledges. However, it is 
more than probable that they will have difficulty in binding onto the crystallographic position, as 
the existence of other alternative binding sites means they can be easily trapped on the ledges.  
It is postulated that as a result of this complex binding process the accumulation and 
aggregation of SC0 dimers, retards surface integration. This is further hampered by the variety of 
weakly bound hydration sites for the molecule and dimer (ESI 3.4.2), the face (ESI 3.4.4) and 
ledge (ESI 3.4.5)  and leads to the formation of the dense nanodroplets observed on the surface 
of (100)OZPNI. 
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Figure 6 Interaction energies of SC0 dimer on OZPN I [001] ledge model on perfect (100)OZPNI 
surface. The reference energy of SC0 binding on (100)OZPNI face in the crystallographic position is 
shown as a dashed green line. 
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Figure 7 a−f) A selection of representative binding sites for SC0 dimer on [001]OZPNI ledge model 
on a perfect (100)OZPNI surface. 
This result is not dependent on the assumption that the SC0 dimer is the building block. The 
more conformationally flexible monomer, or any of the other possible dimers (ESI 3.4.1) would 
have similar or greater difficulty in accessing the crystallographic site. Some alternative dimers, 
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and many hydrated dimers (given the range of hydration sites on the SC0 dimer (ESI 3.4.2)) or 
any dimer-dimer complexes (ESI 3.4.3) may further block the growth before adding to a 
crystallographic site as SC0 dimers or monomers.  Hence any growth unit other than the SC0 
dimer would further increase the extent of disorder on the surface ledge and further contribute to 
formation of a disordered solute-rich region containing both water and OZPN molecules.  
The influence of OZPN I on the growth of OZPN DD and OZPN DB 
 To investigate why OZPN DD microcrystallites were observed with their (001)OZPNDD face 
firmly attached to the (100)OZPNI face, in contrast to the loosely attached (100)OZPNDB, nanocrystal 
models of both faces were constructed. These represent a small nucleating cluster that is large 
enough to establish the distinct hydrate crystal structures. The two nanocrystal constructs and the 
OZPN I surface are shown in Figure 8. This reveals that the (100)OZPNI face is hydrophobic and 
has a complex local topology, corrugated with large oval shaped peaks and pits. On the other 
hand different functional groups are exposed on the two dihydrate faces, presenting distinct 
chemical environments to the (100)OZPNI substrate face. The hydrophobic surface chemistry is 
also consistent with the observed resistance of OZPN I to wetting. 
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Figure 8 a) Top view of OZPN form I (100) face in a surface representation (white for surface 
bumps to blue pits, height difference about 3 ) and b) vdW atomic representation (atoms are 
color coded: carbon- green, hydrogen- white, sulphur- yellow, oxygen- red, nitrogen- blue); c) 
bottom view of OZPN DD nanocrystal (5x5) showing (001)OZPNDD face; d) bottom view of a 
OZPN DB nanocrystal (4x4) showing (100)OZPNDB face. 
ORIENT was used to find the optimum binding energy of each nanocrystal with (100)OZPNI face 
(normalized to one SC0 dimer), as a function of the relative orientation and height of the two 
faces (Figure 9).  The OZPN DD nanocrystal has a significantly stronger binding energy than 
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OZPN DB for any orientation, with the average differing by 7 kJ/mol per dimer. The weak 
binding between the OZPN DB nanocrystal and OZPN I is fairly independent of their relative 
orientation, consistent with the DB crystallites adhering to (100)OZPNI. The most favorable 
orientations of the OZPN DD nanocrystals are for 90-95¡, consistent with the observed value of 
91¡ ± 2¡ (ESI Figure S7c and S17). The cause of this difference in the interactions between the 
two nanocrystals with (100)OZPNI is apparent from the molecular structure in the most favorable 
orientation (Figure 10). 
 
Figure 9 Interaction energies of (001)OZPNDD and (100)OZPNDB nanocrystals with OZPN I (100) 
face, normalized to be per OZPN dimer. Two different-sized nanocrystals are used for OZPN 
DD, which span the size of the OZPN DB nanocrystal, as a test of size dependence.  Azimuthal 
angle θ=0¡ corresponds to the angle between the [010]OZPNI and the [100]OZPNDD or [010]OZPNDB. 
In the most favorable orientation, the OZPN DD nanocrystal has the piperazine rings of OZPN 
DD in contact with the aromatic and alkyl CHn groups of (100)OZPNI surface, though water 
molecules are also close (Figure 10a). The top view of the attached nanocrystal shows that along 
[100]OZPNDD of the nanocrystal, there is a repeating pattern of close contacts between the bottom 
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of the nanocrystals and the surface bumps. These are largely CH2/CH3 groups of piperazine rings 
and CH from aromatic rings on the substrate. This pattern of close contacts can be seen to shift 
gradually along [010]OZPNDD. However, the size of surface bumps means that nearly all OZPN DD 
unit cells maintain close contact with them. Hence there are close interactions between the 
molecules over a significant fraction of the surface, with quite a good degree of periodic repeats 
over this small area. There is a considerable area of van der Waals contact between the two 
surfaces, which increases the favorable dispersion interactions accounting for the larger binding 
energy. There are still significant void spaces between the two crystal structures. However, if the 
only favorable water binding site on (100)OZPNI (ESI 3.4.4) is occupied, then further water 
molecules could fill the void and hydrogen bond to the water molecules within the DD structure. 
Some relaxation of the nanocrystal could further enhance the binding, but such distortions will 
only be small. Hence, the nanocrystal calculations support the observation that (100)OZPNI 
templates the nucleation of OZPN DD, by favoring the formation of a sufficiently large nucleus 
with the OZPN DD structure to establish the growth of this phase. 
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Figure 10 a) Side-view and top-view of the optimal attachment geometry at θ=90¡ for 
(001)OZPNDD nanocrystal on (100)OZPNI face, with interaction energy of 32.20 kJ/mol per OZPN 
dimer; (b) Side-view and top-view of the optimal attachment geometry at θ=90¡ for (100)OZPNDB 
nanocrystal on (100)OZPNI face, with interaction energy of 18.79 kJ/mol per OZPN dimer. θ=0¡ 
corresponds to the angle between the [010]OZPNI and the [100]OZPNDD  or [010]OZPNDB. Atoms in 
nanocrystals within a vertical distance of 3  of the substrate were shown as CPK model. 
Surface representation color scheme depicts surface height from blue low (pits) to white high 
(bumps). Unit cell vectors are shown in red for (100)OZPNI, white for (001)OZPNDD and yellow for 
(100)OZPNDB. 
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In contrast, the (100)OZPNDB face has less van der Waals contact with the (100)OZPNI surface, with 
only aromatic CH groups in contact with the hydrophobic OZPN surface, giving a smaller 
binding energy in all orientations. These aromatic!aromatic contacts are still approximately 
periodically repeated, but there are significantly fewer close contacts between the other atoms in 
the two surfaces than in OZPN DD, providing less dispersion-stabilized binding (Figure 10c). 
The hydrophobic void space is much larger than for the OZPN DD nanocrystal, requiring a much 
larger cluster of water molecules to make any hydrogen bonding chain between (100)OZPNI N4 
sites and the water molecules in the DB nanocrystal.  
The extensive modelling work (detailed in ESI 3) supports the two-step nucleation process for 
OZPN. Unlike an isotropic spherical (ÒatomicÓ) growth unit, OZPN molecules or dimers have 
difficulty in orienting easily into their crystallographic growth sites. There are multiple hydration 
sites on the ledge face (ESI 3.4.5) but only one on the (100)OZPNI surface, contributing to the 
formation of the dense OZPN/water droplets at ledge sites and impeding OZPN molecules from 
ordering into a crystallographic site, for either adding to the anhydrate or forming a dihydrate 
structure. 
Once the prenucleation dense phase is present and nanodroplet coalescence has occurred, 
(100)OZPNI face is a better match, in terms of functional group interactions, with the (001)OZPNDD 
face structure than (100)OZPNDB. This is only apparent from explicitly modelling the 
intermolecular interactions, as the interaction between OZPN molecules are dominated by 
dispersion interactions. As either dihydrate crystal grows, the registry with the underlying 
surface will gradually decrease, but the nanocrystal models used are of a sufficient size to show 
the difference in the interactions and possibly to establish an effective nucleus for growth.  The 
(100)OZPNI face has only one buried water binding site (ESI 3.4.4), being otherwise hydrophobic, 
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so other waters are only bound by forming a water network. There is a stronger binding energy to 
encourage the formation of OZPN DD nucleus, displacing some of the water network on this 
surface, and for it to be more firmly attached than any crystallites of OZPN DB.   
This hydration study is limited to a specific surface of a specific form of OZPN and in specific 
conditions which differ critically from a slurry conversion, in that there are no particle collisions 
that would refresh or produce different crystal surfaces. The kinetics are ideal for the application 
of AFM and are related to the low solubility of OZPN. However, the slow kinetics leading to 
surface hydrate formation at levels below that which are detected by conventional methods are 
highly relevant to long-term material storage behavior. In this regard, this surface 
characterization approach complements traditional methods of establishing phase stability over 
the shelf-life of the drug product. The epitaxial formation of hydrates is not widely reported,68 
though this probably contributed to the common observation that API dissolution rates may 
decrease with time on storage. This example shows that more work on surface chemistry should 
unravel the complexity of the possible hydration and polymorph transformation pathways of 
pharmaceuticals such as OZPN.  
 
CONCLUSIONS 
The experimental and simulation approaches have shown a two-step nucleation mechanism in 
the formation of OZPN DD on the surface of the dominant face of OZPN I. Significant 
difference in the polymorphic outcome was observed with different stirring conditions owing to 
the reduced influence of the OZPNI surface on nucleation from droplets that have been removed 
from direct contact by shear. In quiescent conditions, only the presence of the thermodynamic 
form OZPN DD was observed on the surface of (100)OZPNI and AFM directly visualizes the 
formation of dense nanodroplets at steps that  are able to grow and coalesce until nucleation 
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occurs. This two-step nucleation process results in a crystal closely bound to the OZPN I surface. 
The crystal form produced is templated by the (100)OZPNI surface which shows a structural 
similarity and energetic preference for OZPN DD over the metastable OZPN DB. Under stirred 
conditions, nanodroplets can be detached from the surface, resulting in the nucleation and 
formation of OZPN DB without any templating effect from (100)OZPNI surface.  
Examination of OZPN I surface properties, i.e. geometry, molecular functionality and crystal 
structure, showed that nucleation of OZPN DD occurs due to stronger intermolecular interactions 
between (100)OZPNI and (001)OZPNDD than with the largest face of OZPN DB. Even though a ledge-
driven epitaxy mechanism was not observed, ledges play an important role in the nucleation 
process, by providing a site for the formation of dense droplets of OZPN and water molecules in 
prenucleation clusters, where the variety of stronger binding sites allows more OZPN SC0 dimers 
to accumulate, faster than onto the terraced surfaces. 
Thus, OZPN hydration provides considerable insights into how pharmaceutical molecules, 
with their far from spherical shapes and highly anisotropic intermolecular interactions, do not 
conform to the models of crystal nucleation and growth for spherical isotropic growth units. 
Different crystalline forms present very different surface and ledge structures, allowing for 
different heteronucleation mechanisms and hence polymorph selectivity.  
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BRIEFS  
 
SYNOPSIS  
The olanzapine anhydrous to dihydrate transformation in water follows a two-step nucleation 
mechanism and the selection of the specific dihydrate polymorphic form is dependent on the 
presence of olanzapine I as a template.  
 
